Single-Cell Secretome Quantification via Barcoded Capture Probes

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting secreted proteins are limited in their ability to quantify the number of copies secreted by a single cell and simultaneously measure protein and gene expression, often relying on bulk measurements and lacking sensitivity in fluorescence analysis.

Innovation Solution

A method involving solid supports with capture probes and secreted factor-binding reagents, combined with oligonucleotide barcodes for hybridization and sequencing, allows for the quantification of secreted factors and nucleic acid targets in individual cells, using unique identifier sequences for precise counting.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional bulk detection methods are used, then the measurement process is simple, but the ability to quantify secreted factors at the single-cell level is lost

Engineering Contradiction:
Improvesingle-cell quantification capabilityVSAvoiddetection system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The detection system is segmented into discrete solid supports (beads), each capable of independently capturing secreted factors from individual cells. This segmentation enables parallel processing of multiple single cells, achieving single-cell resolution while maintaining scalability through the modular bead-based architecture.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Oligonucleotide barcodes serve as intermediary molecules that bridge the connection between captured secreted factors and detectable signals. These barcodes are attached to secreted factors during capture and subsequently amplified and sequenced, converting the physical presence of secreted factors into quantifiable digital data without requiring direct fluorescence measurement.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If fluorescence-based methods are used, then real-time detection is possible, but quantitative accuracy is limited due to fluorescence intensity measurement limitations

Engineering Contradiction:
Improvequantitative accuracy of secreted factor copiesVSAvoiddetection method complexity
Core Design Contradiction:
Measurement precisionVSDifficulty of detecting and measuring

Solution Approach 1:

The patent replaces the optical/fluorescence-based detection system with a sequencing-based detection system. Instead of measuring fluorescence intensity, the method uses oligonucleotide barcode amplification and sequencing, where the number of sequenced barcode reads directly corresponds to the number of secreted factor copies. This substitution eliminates the limitations of fluorescence quantification while providing digital, absolute counting capability.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The method creates multiple copies of oligonucleotide barcodes associated with each secreted factor through PCR amplification. These copied barcodes serve as proxies for the original secreted factors, allowing indirect quantification through sequencing depth. The copying process preserves the quantitative information while enabling scalable detection through molecular amplification.

Inventive Principle:
Principle #26Copying

3Adaptability or versatility

If the number of fluorescence markers is increased to detect more proteins, then the detection capability is improved, but the technical limitations of microscopy or flow cytometry are reached

Engineering Contradiction:
Improvenumber of detectable proteinsVSAvoidmicroscope or flow cytometry limitations
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The solid support system uses universal capture mechanisms (e.g., anti-tag antibodies) that can recognize diverse secreted factors through a common feature (such as a FLAG tag or other epitope). This universal approach allows the same platform to detect any secreted factor that has been engineered with the recognition tag, eliminating the need for factor-specific detection reagents and enabling scalable multiplexing limited only by the number of unique barcodes available.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables quantitative analysis of secreted factors and nucleic acid targets at the single-cell level, overcoming limitations of bulk detection and enhancing the accuracy of protein and gene expression measurements.

Implementation Method 1

each first solid support comprises a plurality of capture probes capable of specifically binding to at least one of the plurality of secreted factors secreted by a single cell

Methodology Applied
Scientific EffectSpecific binding: Adsorption

Implementation Method 2

contacting a plurality of oligonucleotide barcodes with the secreted factor-binding reagent specific oligonucleotides for hybridization

Methodology Applied
Scientific EffectHybridization:

Data Source

PatentUS20250354982A1Single cell secretome analysis
Publication Date: 2025.11.20 BECTON DICKINSON & CO
  • US20250354982A1 patent drawing
  • US20250354982A1 patent drawing
  • US20250354982A1 patent drawing

AI summary

Systems, methods, compositions, and kits for measuring secreted factors from cells are disclosed herein, including those capable of determining single cell secretion activity and protein expression and/or gene expression simultaneously. Disclosed herein include solid supports comprising a plurality of capture probes capable of specifically binding to at least one of the plurality of secreted factors secreted by a single cell. Also disclosed herein include secreted factor-binding reagents capable of specifically binding to a secreted factor bound by a capture probe. A secreted factor-binding reagent can comprise a secreted factor-binding reagent specific oligonucleotide comprising a unique factor identifier sequence for the secreted factor-binding reagent.